Skip to main content
. 2016 Aug 11;11(8):e0160559. doi: 10.1371/journal.pone.0160559

Table 1. Baseline anthropometric characteristics, baseline 5-km time-trial results, and baseline fasting blood glucose results.

Variables Protandim® Placebo p -value Combined Mean
(n = 19) (n = 19) (n = 38)
Age (yrs) 34 (6) 35 (8) 0.56 34 (7)
[23 to 44] [20 to 46] [20 to 46]
Weight (kg) 68.1 (11.4) 64.6 (11.1) 0.34 66.4 (11.2)
[42.6 to 88.6] [47.5 to 88.5] [42.6 to 88.6]
Height (cm) 174 (10) 171 (11) 0.30 172 (11)
[155 to 191] [155 to 188] [155 to 191]
BMI (kg/m2) 22.3 (2.1) 22.1 (2.7) 0.82 22.2 (2.4)
[17.7 to 26.3] [18.6 to 27.6] [17.7 to 27.6]
5-km time (sec) 1225 (136) 1210 (121) 0.72 1217 (128)
[1047 to 1450] [1029 to 1469] [1029 to 1469]
5-km time (min) 20.4 (2.3) 20.2 (2.0) 0.72 20.3 (2.1)
[17.5 to 24.2] [17.2 to 24.5] [17.2 to 24.5]
% of world record for age & gender 68 (4%) 69 (6%) 0.34 69 (5%)
[61% to 76%] [60% to 81%] [60% to 81%]
Fast blood glucose (mg/dL) 90 (5) 89 (9) 0.73 90 (7)
[81 to 97] [73 to 104] [73 to 104]

Mean (SD), [range], 22 subjects (58% of the sample) was classified as Local Class, 15 subjects (40% of the sample) was classified as Regional Class, one subject (3% of the sample) was classified as National Class. Baseline 5-km time trial performance was taken as the best result between two baseline 5-km time trials held one week apart. Baseline fasting blood glucose values was the average fasting blood glucose values for both baseline sessions held one week apart. All variables were normally distributed (Shapiro-Wilk test p > 0.05 for all).